Genprex Partners with US CDMO to Scale Up Diabetes Gene Therapy Manufacturing
Genprex has partnered with a US-based CDMO to scale up cGMP manufacturing of its AAV-based diabetes gene therapy candidate, supporting IND-enabling studies and future clinical trials.
Treatments For Cancer | 19/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy